| 1 | Nature Reviews Microbiology | 124 | 99th | Q1 | SCIE | – | No |
| 2 | Immunity | 44.9 | 99th | Q1 | SCIE | – | No |
| 3 | The Lancet Infectious Diseases | 39.2 | 99th | Q1 | SCIE | – | No |
| 4 | Cellular and Molecular Immunology | 33.9 | 99th | Q1 | SCIE | – | No |
| 5 | Drug Resistance Updates | 29.1 | 98th | Q1 | SCIE | – | No |
| 6 | Clinical Microbiology Reviews | 28.9 | 98th | Q1 | SCIE | – | No |
| 7 | FEMS Microbiology Reviews | 26 | 98th | Q1 | SCIE | – | Yes |
| 8 | Trends in Microbiology | 25.9 | 97th | Q1 | SCIE | – | No |
| 9 | The Lancet Microbe | 24.8 | 97th | Q1 | SCIE | – | Yes |
| 10 | Gut Microbes | 19.5 | 97th | Q1 | SCIE | – | Yes |
| 11 | The Lancet HIV | 18.9 | 97th | Q1 | SCIE | – | No |
| 12 | Reviews in Medical Virology | 17.4 | 96th | Q1 | SCIE | – | No |
| 13 | Clinical Infectious Diseases | 17.1 | 96th | Q1 | SCIE | – | No |
| 14 | Clinical Microbiology and Infection | 17.1 | 96th | Q1 | SCIE | – | No |
| 15 | Current Opinion in Microbiology | 14.9 | 95th | Q1 | SCIE | – | No |
| 16 | Emerging Microbes and Infections | 14.1 | 95th | Q1 | SCIE | – | Yes |
| 17 | The Lancet Regional Health - Western Pacific | 13.8 | 95th | Q1 | SCIE, SSCI | – | Yes |
| 18 | Eurosurveillance | 13.6 | 95th | Q1 | SCIE | – | Yes |
| 19 | Journal of the European Academy of Dermatology and Venereology | 13.2 | 94th | Q1 | SCIE | – | No |
| 20 | Microbiology and Molecular Biology Reviews | 12.8 | 94th | Q1 | SCIE | – | No |
| 21 | British Journal of Biomedical Science | 12.7 | 94th | Q1 | SCIE | – | Yes |
| 22 | Experientia Supplementum (2012) | 12 | 94th | Q1 | – | – | No |
| 23 | Tumour Virus Research | 10.5 | 93rd | Q1 | ESCI | – | Yes |
| 24 | Antibiotics | 10.2 | 93rd | Q1 | SCIE | – | Yes |
| 25 | Infectious Diseases of Poverty | 10.2 | 93rd | Q1 | SCIE | – | Yes |
| 26 | Trends in Parasitology | 10.2 | 92nd | Q1 | SCIE | – | No |
| 27 | Journal of Infection | 10.1 | 92nd | Q1 | SCIE | – | Yes |
| 28 | Mycology | 10 | 92nd | Q1 | ESCI | – | Yes |
| 29 | Journal of Medical Virology | 9.9 | 92nd | Q1 | SCIE | – | No |
| 30 | npj Vaccines | 9.8 | 91st | Q1 | SCIE | – | Yes |
| 31 | Frontiers in Cellular and Infection Microbiology | 9.6 | 91st | Q1 | SCIE | – | Yes |
| 32 | Emerging Infectious Diseases | 9.5 | 91st | Q1 | SCIE | – | Yes |
| 33 | Immune Network | 9.3 | 90th | Q1 | SCIE | – | No |
| 34 | Infectious Diseases and Therapy | 9.3 | 90th | Q1 | SCIE | – | Yes |
| 35 | Expert Review of Anti-Infective Therapy | 9.1 | 90th | Q1 | SCIE | – | No |
| 36 | International Journal of Infectious Diseases | 9.1 | 90th | Q1 | SCIE | – | Yes |
| 37 | Journal of Infectious Diseases | 8.8 | 89th | Q1 | SCIE | – | No |
| 38 | Travel Medicine and Infectious Disease | 8.8 | 89th | Q1 | SCIE | – | Yes |
| 39 | Infectious Diseases in Obstetrics and Gynecology | 8.7 | 89th | Q1 | – | – | No |
| 40 | The Lancet Regional Health - Southeast Asia | 8.7 | 89th | Q1 | ESCI | – | Yes |
| 41 | Antimicrobial Resistance and Infection Control | 8.4 | 88th | Q1 | SCIE | – | Yes |
| 42 | International Journal of Antimicrobial Agents | 8.3 | 88th | Q1 | SCIE | – | No |
| 43 | Current Research in Microbial Sciences | 8.2 | 88th | Q1 | ESCI | – | Yes |
| 44 | Journal of Biosafety and Biosecurity | 8.2 | 87th | Q1 | ESCI | – | Yes |
| 45 | Journal of Oral Microbiology | 8.2 | 87th | Q1 | SCIE | – | Yes |
| 46 | Helicobacter | 8 | 87th | Q1 | SCIE | – | No |
| 47 | Infectious Disease Clinics of North America | 8 | 87th | Q1 | SCIE | – | No |
| 48 | Antimicrobial Agents and Chemotherapy | 8 | 86th | Q1 | SCIE | – | Yes |
| 49 | Chinese Medical Journal Pulmonary and Critical Care Medicine | 8 | 86th | Q1 | ESCI | – | No |
| 50 | Current HIV/AIDS Reports | 8 | 86th | Q1 | SCIE | – | No |
| 51 | Retrovirology | 7.9 | 86th | Q1 | SCIE | – | Yes |
| 52 | Journal of Microbiology, Immunology and Infection | 7.8 | 85th | Q1 | SCIE | – | Yes |
| 53 | Journal of Infection and Public Health | 7.7 | 85th | Q1 | SCIE | – | Yes |
| 54 | Vaccines | 7.7 | 85th | Q1 | SCIE | – | Yes |
| 55 | Annals of Clinical Microbiology and Antimicrobials | 7.6 | 84th | Q1 | SCIE | – | Yes |
| 56 | Influenza and other Respiratory Viruses | 7.6 | 84th | Q1 | SCIE | – | Yes |
| 57 | Viruses | 7.6 | 84th | Q1 | SCIE | – | Yes |
| 58 | Microbiology Spectrum | 7.5 | 84th | Q1 | SCIE | – | Yes |
| 59 | Infection | 7.4 | 83rd | Q1 | SCIE | – | No |
| 60 | Virologica Sinica | 7.3 | 83rd | Q1 | SCIE | – | No |
| 61 | Virulence | 7.2 | 83rd | Q1 | SCIE | – | Yes |
| 62 | Ticks and Tick-borne Diseases | 7.1 | 82nd | Q1 | SCIE | – | Yes |
| 63 | Current Opinion in Infectious Diseases | 7 | 82nd | Q1 | SCIE | – | No |
| 64 | Pathogens and Global Health | 7 | 82nd | Q1 | SCIE | – | No |
| 65 | Journal of Clinical Virology | 6.9 | 82nd | Q1 | SCIE | – | No |
| 66 | Journal of the International AIDS Society | 6.8 | 81st | Q1 | SCIE | – | Yes |
| 67 | Mycoses | 6.7 | 81st | Q1 | SCIE | – | No |
| 68 | Pathogens | 6.7 | 81st | Q1 | SCIE | – | Yes |
| 69 | Journal of Antimicrobial Chemotherapy | 6.6 | 81st | Q1 | SCIE | – | No |
| 70 | ACS Infectious Diseases | 6.5 | 80th | Q1 | SCIE | – | No |
| 71 | Hepatology Research | 6.5 | 80th | Q1 | SCIE | – | No |
| 72 | One Health | 6.5 | 80th | Q1 | SCIE | – | Yes |
| 73 | Journal of Travel Medicine | 6.5 | 79th | Q1 | SCIE | – | No |
| 74 | Gut Pathogens | 6.4 | 79th | Q1 | SCIE | – | Yes |
| 75 | Vaccine | 6.4 | 79th | Q1 | SCIE | – | No |
| 76 | Pathogens and Disease | 6.3 | 79th | Q1 | – | – | No |
| 77 | Frontiers in Fungal Biology | 6.3 | 78th | Q1 | ESCI | – | Yes |
| 78 | PLOS Neglected Tropical Diseases | 6.3 | 78th | Q1 | SCIE | – | Yes |
| 79 | Parasites and Vectors | 6.2 | 78th | Q1 | SCIE | – | Yes |
| 80 | AIDS Patient Care and STDs | 6.2 | 77th | Q1 | SCIE, SSCI | – | No |
| 81 | Infectious Medicine | 6.2 | 77th | Q1 | ESCI | – | Yes |
| 82 | Virus Research | 6.2 | 77th | Q1 | SCIE | – | Yes |
| 83 | Microbial Risk Analysis | 6.1 | 77th | Q1 | SCIE | – | No |
| 84 | International Journal for Parasitology | 6.1 | 76th | Q1 | SCIE | – | No |
| 85 | Virology Journal | 6.1 | 76th | Q1 | SCIE | – | Yes |
| 86 | Current Fungal Infection Reports | 6 | 76th | Q1 | ESCI | – | No |
| 87 | Tropical Medicine and Infectious Disease | 6 | 76th | Q1 | SCIE | – | Yes |
| 88 | Current Infectious Disease Reports | 5.9 | 75th | Q1 | SCIE | – | No |
| 89 | Microbial Pathogenesis | 5.9 | 75th | Q1 | SCIE | – | No |
| 90 | Open Forum Infectious Diseases | 5.9 | 75th | Q1 | SCIE | – | Yes |
| 91 | Current Opinion in HIV and AIDS | 5.8 | 74th | Q2 | SCIE | – | No |
| 92 | Infection Control and Hospital Epidemiology | 5.8 | 74th | Q2 | SCIE | – | No |
| 93 | International Journal for Parasitology: Drugs and Drug Resistance | 5.8 | 74th | Q2 | SCIE | – | Yes |
| 94 | Journal of Hospital Infection | 5.8 | 74th | Q2 | SCIE | – | No |
| 95 | Infection and Immunity | 5.7 | 73rd | Q2 | SCIE | – | Yes |
| 96 | Biosafety and Health | 5.6 | 73rd | Q2 | ESCI | – | Yes |
| 97 | HIV Medicine | 5.6 | 73rd | Q2 | SCIE | – | No |
| 98 | Advances in Virus Research | 5.6 | 72nd | Q2 | – | – | No |
| 99 | Anaerobe | 5.6 | 72nd | Q2 | SCIE | – | No |
| 100 | Infection and Drug Resistance | 5.6 | 72nd | Q2 | SCIE | – | Yes |
| 101 | Infectious Disease Modelling | 5.6 | 72nd | Q2 | ESCI | – | Yes |
| 102 | Current Research in Translational Medicine | 5.5 | 71st | Q2 | SCIE | – | No |
| 103 | Infection, Genetics and Evolution | 5.5 | 71st | Q2 | SCIE | – | Yes |
| 104 | Journal of Preventive Medicine and Hygiene | 5.5 | 71st | Q2 | – | – | No |
| 105 | Malaria Journal | 5.5 | 71st | Q2 | SCIE | – | Yes |
| 106 | Infectious Agents and Cancer | 5.4 | 70th | Q2 | SCIE | – | Yes |
| 107 | Innate Immunity | 5.4 | 70th | Q2 | SCIE | – | Yes |
| 108 | Parasitology | 5.4 | 70th | Q2 | SCIE | – | Yes |
| 109 | Current Clinical Microbiology Reports | 5.4 | 69th | Q2 | ESCI | – | No |
| 110 | JAC-Antimicrobial Resistance | 5.3 | 69th | Q2 | ESCI | – | Yes |
| 111 | Therapeutic Advances in Infectious Disease | 5.3 | 69th | Q2 | ESCI | – | Yes |
| 112 | Zoonoses and Public Health | 5.3 | 69th | Q2 | SCIE | – | No |
| 113 | Canadian Journal of Infectious Diseases and Medical Microbiology | 5.3 | 68th | Q2 | SCIE | – | Yes |
| 114 | American Journal of Infection Control | 5.2 | 68th | Q2 | SCIE | – | No |
| 115 | Epidemics | 5.2 | 68th | Q2 | SCIE | – | Yes |
| 116 | Tropical Medicine and Health | 5.2 | 68th | Q2 | SCIE | – | Yes |
| 117 | AIDS and Behavior | 5.1 | 67th | Q2 | SSCI | – | No |
| 118 | Infezioni in Medicina | 5.1 | 67th | Q2 | – | – | No |
| 119 | International Journal of Tuberculosis and Lung Disease | 5.1 | 67th | Q2 | SCIE | – | No |
| 120 | Fungal Biology | 5.1 | 66th | Q2 | SCIE | – | No |
| 121 | Infection and Chemotherapy | 5.1 | 66th | Q2 | ESCI | – | Yes |
| 122 | Microbes and Infection | 5 | 66th | Q2 | SCIE | – | No |
| 123 | Transplant Infectious Disease | 5 | 66th | Q2 | SCIE | – | No |
| 124 | European Journal of Clinical Microbiology and Infectious Diseases | 5 | 65th | Q2 | SCIE | – | No |
| 125 | Frontiers in Antibiotics | 5 | 65th | Q2 | ESCI | – | Yes |
| 126 | Antiviral Therapy | 4.9 | 65th | Q2 | SCIE | – | Yes |
| 127 | AIDS | 4.8 | 64th | Q2 | SCIE | – | No |
| 128 | Current Tropical Medicine Reports | 4.8 | 64th | Q2 | ESCI | – | No |
| 129 | Journal of Migration and Health | 4.8 | 64th | Q2 | ESCI | – | Yes |
| 130 | Journal of Water and Health | 4.8 | 64th | Q2 | SCIE | – | Yes |
| 131 | Acta Tropica | 4.7 | 63rd | Q2 | SCIE | – | No |
| 132 | BMC Infectious Diseases | 4.6 | 63rd | Q2 | SCIE | – | Yes |
| 133 | Journal of the Pediatric Infectious Diseases Society | 4.6 | 63rd | Q2 | SCIE | – | No |
| 134 | Sexually Transmitted Infections | 4.6 | 63rd | Q2 | SCIE | – | No |
| 135 | Epidemiology and Infection | 4.6 | 62nd | Q2 | SCIE | – | Yes |
| 136 | Tuberculosis and Respiratory Diseases | 4.6 | 62nd | Q2 | ESCI | – | Yes |
| 137 | Medical Mycology | 4.5 | 62nd | Q2 | SCIE | – | No |
| 138 | Journal of Medical Mycology | 4.5 | 61st | Q2 | SCIE | – | No |
| 139 | Parasite Epidemiology and Control | 4.5 | 61st | Q2 | ESCI | – | Yes |
| 140 | China CDC Weekly | 4.4 | 61st | Q2 | SCIE, SSCI | – | No |
| 141 | Infectious Diseases | 4.4 | 61st | Q2 | SCIE | – | No |
| 142 | Comparative Immunology, Microbiology and Infectious Diseases | 4.4 | 60th | Q2 | SCIE | – | No |
| 143 | Parasite | 4.4 | 60th | Q2 | SCIE | – | Yes |
| 144 | Tuberculosis | 4.3 | 60th | Q2 | SCIE | – | No |
| 145 | Frontiers in Allergy | 4.3 | 59th | Q2 | ESCI | – | Yes |
| 146 | Interdisciplinary Perspectives on Infectious Diseases | 4.3 | 59th | Q2 | – | – | Yes |
| 147 | Intervirology | 4.3 | 59th | Q2 | SCIE | – | Yes |
| 148 | Tropical Medicine and International Health | 4.3 | 59th | Q2 | SCIE | – | No |
| 149 | Journal of Viral Hepatitis | 4.3 | 58th | Q2 | SCIE | – | No |
| 150 | Pathogens and Immunity | 4.3 | 58th | Q2 | – | – | Yes |
| 151 | Tropical Diseases, Travel Medicine and Vaccines | 4.3 | 58th | Q2 | ESCI | – | Yes |
| 152 | Infectious Disease Reports | 4.2 | 58th | Q2 | ESCI | – | Yes |
| 153 | International Journal of Medical Microbiology | 4.2 | 57th | Q2 | SCIE | – | Yes |
| 154 | Spatial and Spatio-temporal Epidemiology | 4.2 | 57th | Q2 | ESCI | – | No |
| 155 | Vaccine: X | 4.2 | 57th | Q2 | ESCI | – | Yes |
| 156 | Frontiers in Virology | 4.1 | 56th | Q2 | ESCI | – | Yes |
| 157 | Journal of Chemotherapy | 4.1 | 56th | Q2 | SCIE | – | No |
| 158 | Journal of Medical Entomology | 4.1 | 56th | Q2 | SCIE | – | No |
| 159 | Topics in Antiviral Medicine | 4.1 | 56th | Q2 | – | – | No |
| 160 | International Journal for Parasitology: Parasites and Wildlife | 4 | 55th | Q2 | SCIE | – | Yes |
| 161 | Parasitology International | 4 | 55th | Q2 | SCIE | – | No |
| 162 | Parasitology Research | 4 | 55th | Q2 | SCIE | – | No |
| 163 | New Microbes and New Infections | 3.9 | 54th | Q2 | ESCI | – | Yes |
| 164 | Prion | 3.9 | 54th | Q2 | SCIE | – | Yes |
| 165 | Infectious Diseases Now | 3.8 | 54th | Q2 | SCIE | – | No |
| 166 | Frontiers in Tropical Diseases | 3.8 | 53rd | Q2 | – | – | Yes |
| 167 | Journal of Bone and Joint Infection | 3.8 | 53rd | Q2 | ESCI | – | Yes |
| 168 | Mycobiology | 3.7 | 53rd | Q2 | SCIE | – | Yes |
| 169 | Vector-Borne and Zoonotic Diseases | 3.7 | 53rd | Q2 | SCIE | – | No |
| 170 | Annali di Igiene Medicina Preventiva e di Comunita | 3.7 | 52nd | Q2 | ESCI | – | No |
| 171 | Journal of Clinical Tuberculosis and Other Mycobacterial Diseases | 3.7 | 52nd | Q2 | ESCI | – | Yes |
| 172 | Pediatric Infectious Disease Journal | 3.7 | 52nd | Q2 | SCIE | – | No |
| 173 | Zoonoses (Ireland) | 3.7 | 51st | Q2 | ESCI | – | Yes |
| 174 | HIV/AIDS - Research and Palliative Care | 3.6 | 51st | Q2 | ESCI | – | Yes |
| 175 | Journal of Venomous Animals and Toxins Including Tropical Diseases | 3.6 | 51st | Q2 | SCIE | – | Yes |
| 176 | Journal of Virus Eradication | 3.6 | 51st | Q2 | SCIE | – | Yes |
| 177 | Chemotherapy | 3.6 | 50th | Q2 | SCIE | – | No |
| 178 | Frontiers in Epidemiology | 3.5 | 50th | Q2 | ESCI | – | Yes |
| 179 | Global Epidemiology | 3.5 | 50th | Q2 | – | – | Yes |
| 180 | Infection Prevention in Practice | 3.5 | 50th | Q2 | ESCI | – | Yes |
| 181 | AIDS Reviews | 3.5 | 49th | Q3 | SCIE | – | No |
| 182 | Revista da Sociedade Brasileira de Medicina Tropical | 3.5 | 49th | Q3 | SCIE | – | Yes |
| 183 | Infection, Disease and Health | 3.4 | 49th | Q3 | ESCI | – | No |
| 184 | Experimental Parasitology | 3.3 | 48th | Q3 | SCIE | – | No |
| 185 | Transactions of the Royal Society of Tropical Medicine and Hygiene | 3.3 | 48th | Q3 | SCIE | – | No |
| 186 | VirusDisease | 3.3 | 48th | Q3 | ESCI | – | No |
| 187 | Brazilian Journal of Infectious Diseases | 3.2 | 48th | Q3 | SCIE | – | Yes |
| 188 | Mediterranean Journal of Hematology and Infectious Diseases | 3.2 | 47th | Q3 | SCIE | – | Yes |
| 189 | Journal of Infection and Chemotherapy | 3.1 | 47th | Q3 | SCIE | – | No |
| 190 | Vacunas | 3.1 | 47th | Q3 | – | – | No |
| 191 | Acta Microbiologica et Immunologica Hungarica | 3.1 | 46th | Q3 | SCIE | – | No |
| 192 | Clinical Epidemiology and Global Health | 3.1 | 46th | Q3 | ESCI | – | Yes |
| 193 | Italian Journal of Dermatology and Venereology | 3.1 | 46th | Q3 | SCIE | – | No |
| 194 | IJID Regions | 3 | 46th | Q3 | ESCI | – | Yes |
| 195 | American Journal of Tropical Medicine and Hygiene | 3 | 45th | Q3 | SCIE | – | No |
| 196 | Journal of Ophthalmic Inflammation and Infection | 3 | 45th | Q3 | ESCI | – | Yes |
| 197 | Journal of the International Association of Providers of AIDS Care | 3 | 45th | Q3 | ESCI | – | Yes |
| 198 | Sahara J | 3 | 45th | Q3 | SSCI | – | Yes |
| 199 | Advances in Virology | 2.9 | 44th | Q3 | ESCI | – | Yes |
| 200 | GERMS | 2.9 | 44th | Q3 | ESCI | – | No |
| 201 | Sexually Transmitted Diseases | 2.9 | 44th | Q3 | SCIE | – | No |
| 202 | Frontiers in Parasitology | 2.9 | 43rd | Q3 | ESCI | – | Yes |
| 203 | Journal of Parasitology Research | 2.9 | 43rd | Q3 | ESCI | – | Yes |
| 204 | Osong Public Health and Research Perspectives | 2.9 | 43rd | Q3 | ESCI | – | Yes |
| 205 | Surgical Infections | 2.9 | 43rd | Q3 | SCIE | – | No |
| 206 | AIDS Research and Human Retroviruses | 2.9 | 42nd | Q3 | SCIE | – | No |
| 207 | Medical Mycology Journal | 2.9 | 42nd | Q3 | ESCI | – | No |
| 208 | Journal of Clinical Virology Plus | 2.8 | 42nd | Q3 | ESCI | – | Yes |
| 209 | Clinical and Experimental Vaccine Research | 2.8 | 41st | Q3 | ESCI | – | Yes |
| 210 | Diagnostic Microbiology and Infectious Disease | 2.8 | 41st | Q3 | SCIE | – | No |
| 211 | Japanese Journal of Infectious Diseases | 2.8 | 41st | Q3 | SCIE | – | No |
| 212 | Sexual Health | 2.7 | 41st | Q3 | SCIE, SSCI | – | No |
| 213 | International Journal of Mycobacteriology | 2.7 | 40th | Q3 | ESCI | – | Yes |
| 214 | Southern African Journal of HIV Medicine | 2.7 | 40th | Q3 | SCIE | – | Yes |
| 215 | International Journal of STD and AIDS | 2.6 | 40th | Q3 | SCIE | – | No |
| 216 | Recent Advances in Anti-Infective Drug Discovery | 2.5 | 40th | Q3 | – | – | No |
| 217 | Decoding Infection and Transmission | 2.5 | 39th | Q3 | – | – | Yes |
| 218 | Parasites, Hosts and Diseases | 2.5 | 39th | Q3 | SCIE | – | No |
| 219 | Tropical Parasitology | 2.5 | 39th | Q3 | – | – | No |
| 220 | Indian Journal of Dermatology, Venereology and Leprology | 2.5 | 38th | Q3 | SCIE | – | No |
| 221 | IJID One Health | 2.4 | 38th | Q3 | – | – | Yes |
| 222 | International Journal of One Health | 2.4 | 38th | Q3 | ESCI | – | Yes |
| 223 | Revista do Instituto de Medicina Tropical de Sao Paulo | 2.4 | 38th | Q3 | SCIE | – | Yes |
| 224 | Clinical Infection in Practice | 2.4 | 37th | Q3 | – | – | Yes |
| 225 | Current Medical Mycology | 2.4 | 37th | Q3 | – | – | Yes |
| 226 | Journal of Infection in Developing Countries | 2.4 | 37th | Q3 | SCIE | – | Yes |
| 227 | Ecology and Control of Vector-Borne Diseases | 2.4 | 36th | Q3 | – | – | No |
| 228 | Enfermedades Infecciosas y Microbiologia Clinica | 2.4 | 36th | Q3 | SCIE | – | No |
| 229 | Indian Dermatology Online Journal | 2.3 | 36th | Q3 | ESCI | – | Yes |
| 230 | Journal of Tropical Pediatrics | 2.3 | 36th | Q3 | SCIE | – | No |
| 231 | African Journal of Infectious Diseases | 2.3 | 35th | Q3 | – | – | No |
| 232 | AIDS Research and Treatment | 2.3 | 35th | Q3 | ESCI | – | Yes |
| 233 | Antimicrobial Stewardship and Healthcare Epidemiology | 2.3 | 35th | Q3 | ESCI | – | Yes |
| 234 | Medical Mycology Case Reports | 2.3 | 35th | Q3 | ESCI | – | Yes |
| 235 | African Journal of AIDS Research | 2.2 | 34th | Q3 | SCIE, SSCI | – | No |
| 236 | HIV Research and Clinical Practice | 2.2 | 34th | Q3 | SCIE | – | Yes |
| 237 | Indian Journal of Medical Microbiology | 2.2 | 34th | Q3 | SCIE | – | No |
| 238 | Acta Virologica | 2.2 | 33rd | Q3 | – | – | Yes |
| 239 | Infectious Microbes and Diseases | 2.1 | 33rd | Q3 | ESCI | – | Yes |
| 240 | Journal of Vector Borne Diseases | 2.1 | 33rd | Q3 | SCIE | – | Yes |
| 241 | African Journal of Thoracic and Critical Care Medicine | 2 | 33rd | Q3 | ESCI | – | Yes |
| 242 | COVID | 2 | 32nd | Q3 | ESCI | – | Yes |
| 243 | Revista Iberoamericana de Micologia | 2 | 32nd | Q3 | SCIE | – | No |
| 244 | Western Pacific Surveillance and Response Journal : WPSAR | 2 | 32nd | Q3 | ESCI | – | Yes |
| 245 | AIDS Education and Prevention | 2 | 31st | Q3 | SSCI | – | No |
| 246 | Journal of Infection Prevention | 2 | 31st | Q3 | ESCI | – | No |
| 247 | Indian Journal of Tuberculosis | 1.9 | 31st | Q3 | – | – | No |
| 248 | Iranian Journal of Parasitology | 1.9 | 31st | Q3 | SCIE | – | Yes |
| 249 | IJTLD Open | 1.9 | 30th | Q3 | – | – | Yes |
| 250 | Journal of Arthropod-Borne Diseases | 1.9 | 30th | Q3 | SCIE | – | Yes |
| 251 | Journal of Global Infectious Diseases | 1.9 | 30th | Q3 | ESCI | – | Yes |
| 252 | JAMMI | 1.8 | 30th | Q3 | ESCI | – | No |
| 253 | International Maritime Health | 1.8 | 29th | Q3 | ESCI | – | Yes |
| 254 | Iranian Journal of Medical Microbiology | 1.8 | 29th | Q3 | – | – | No |
| 255 | Communicable Diseases Intelligence | 1.7 | 29th | Q3 | ESCI | – | No |
| 256 | Tropical Biomedicine | 1.7 | 28th | Q3 | SCIE | – | No |
| 257 | Open AIDS Journal | 1.6 | 28th | Q3 | – | – | No |
| 258 | Voprosy Virusologii | 1.6 | 28th | Q3 | – | – | Yes |
| 259 | Acta Dermatovenerologica Alpina, Pannonica et Adriatica | 1.6 | 27th | Q3 | ESCI | – | No |
| 260 | IDCases | 1.6 | 27th | Q3 | ESCI | – | Yes |
| 261 | Clinical Microbiology Newsletter | 1.5 | 27th | Q3 | – | – | No |
| 262 | Current HIV Research | 1.5 | 27th | Q3 | SCIE | – | No |
| 263 | Mikrobiyoloji Bulteni | 1.5 | 27th | Q3 | SCIE | – | No |
| 264 | Anti-Infective Agents | 1.4 | 26th | Q3 | – | – | No |
| 265 | Epidemiologiya i Vaktsinoprofilaktika | 1.4 | 26th | Q3 | – | – | Yes |
| 266 | Infectious Diseases and Immunity | 1.4 | 26th | Q3 | ESCI | – | Yes |
| 267 | Infektsionnye Bolezni | 1.3 | 25th | Q3 | – | – | No |
| 268 | Leprosy Review | 1.3 | 25th | Q3 | SCIE | – | Yes |
| 269 | International Journal of Dermatology and Venereology | 1.2 | 25th | Q3 | – | – | Yes |
| 270 | Zhongguo ji sheng chong xue yu ji sheng chong bing za zhi = Chinese journal of parasitology & parasitic diseases | 1.2 | 25th | Q3 | – | – | No |
| 271 | Archives of Pediatric Infectious Diseases | 1.2 | 24th | Q4 | ESCI | – | No |
| 272 | Tropical Doctor | 1.2 | 24th | Q4 | SCIE | – | No |
| 273 | Virologie | 1.2 | 24th | Q4 | SCIE | – | No |
| 274 | Chinese Journal of Schistosomiasis Control | 1.1 | 23rd | Q4 | – | – | No |
| 275 | Chinese Journal of Tuberculosis and Respiratory Diseases | 1.1 | 23rd | Q4 | – | – | No |
| 276 | Problemy Osobo Opasnykh Infektsii | 1.1 | 23rd | Q4 | – | – | Yes |
| 277 | Tuberculosis and Lung Diseases | 1.1 | 23rd | Q4 | – | – | Yes |
| 278 | Chinese Journal of Clinical Infectious Diseases | 1 | 22nd | Q4 | – | – | No |
| 279 | Indian Journal of Sexually Transmitted Diseases and AIDS | 1 | 22nd | Q4 | ESCI | – | No |
| 280 | Jundishapur Journal of Microbiology | 1 | 22nd | Q4 | SCIE | – | No |
| 281 | Russian Journal of Infection and Immunity | 1 | 22nd | Q4 | ESCI | – | Yes |
| 282 | Academia Biology | 1 | 21st | Q4 | – | – | Yes |
| 283 | Kliniceskaa Mikrobiologia i Antimikrobnaa Himioterapia | 1 | 21st | Q4 | – | – | Yes |
| 284 | Ethiopian Journal of Health Development | 0.9 | 21st | Q4 | SCIE, SSCI | – | No |
| 285 | Epidemiologie, Mikrobiologie, Imunologie | 0.9 | 20th | Q4 | SCIE | – | No |
| 286 | International Journal of Medical Parasitology and Epidemiology Sciences | 0.9 | 20th | Q4 | – | – | No |
| 287 | Journal of Global Health Science | 0.9 | 20th | Q4 | – | – | No |
| 288 | Vestnik Dermatologii i Venerologii | 0.9 | 20th | Q4 | – | – | Yes |
| 289 | HIV and AIDS Review | 0.9 | 19th | Q4 | ESCI | – | Yes |
| 290 | HIV Infection and Immunosuppressive Disorders | 0.8 | 19th | Q4 | – | – | No |
| 291 | Microbes and Infectious Diseases | 0.8 | 19th | Q4 | – | – | No |
| 292 | Egyptian Journal of Medical Microbiology (Egypt) | 0.8 | 18th | Q4 | – | – | No |
| 293 | Iranian Journal of Health and Environment | 0.8 | 18th | Q4 | – | – | Yes |
| 294 | Journal of Zoonotic Diseases | 0.8 | 18th | Q4 | – | – | Yes |
| 295 | Avicenna Journal of Clinical Microbiology and Infection | 0.8 | 17th | Q4 | – | – | No |
| 296 | Chinese Journal of Infection Control | 0.8 | 17th | Q4 | – | – | No |
| 297 | Journal of HIV/AIDS and Social Services | 0.8 | 17th | Q4 | – | – | No |
| 298 | Mediterranean Journal of Infection, Microbes and Antimicrobials | 0.8 | 17th | Q4 | ESCI | – | Yes |
| 299 | Chinese Journal of Infection and Chemotherapy | 0.7 | 16th | Q4 | – | – | No |
| 300 | Infection, Epidemiology and Microbiology | 0.7 | 16th | Q4 | – | – | Yes |